Nespresso, the worldwide reference for highest-quality portioned premium coffee, announced today the launch of the second phase of its television advertising campaign “The best café. Yours.” The U.S. and Canada campaign further increases brand awareness among coffee lovers amidst the recent growth of the single serve coffee market. Nespresso has enlisted Oscar-winning actress and coffee lover Penelope Cruz to star in the 30-second television spot as she epitomizes the sophistication, elegance and passion of the brand.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59154-nespresso-what-else-penelope-cruz
Made to your greatest good results at Mixed Martial Arts is our MMA office in Clinton, Maryland. After you phase into our office, you’ll quickly realize that this is certainly no ordinary mixed martial arts academy, but is something genuinely exceptional.
New entertainment integrations and social media initiatives move the “ugly truth” campaign into a new phase this month, further seeding important tobacco-related facts and messages with teens and young adults. The latest advertising campaign from truth – the nation’s largest youth smoking prevention campaign – features its first television ads since 2010, and a host of marketing and digital tools to educate and connect with teens and young people through a range of digital media initiatives and entertainment integrations.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62254-truth-campaign-gets-uglier-entertainment-integrations-expand-conversation
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Carowinds is unveiling plans to bring a fresh and exciting Carolina coastal experience to guests with a historic waterpark expansion in 2016. The transformation is part of the park’s commitment to celebrate Carowinds’ heritage as the place where the Carolinas come together, creating an “aquatic playground” with thrilling new attractions, new amenities and a new coastal name - Carolina Harbor.
Carolina Harbor waterpark will be included with park admission and will offer guests relaxing moments of tranquility and refreshing thrills by the “shores”, plus delivers a best day ever guest experience. The addition is the latest phase in a $50 million plus multi-year expansion at Carowinds, an effort kicked off by building the world’s tallest and fastest giga coaster, Fury 325, as well as new park food offerings which are regionally relevant.
To view the multimedia release go to:
http://www.multivu.com/players/English/7477452-carowinds-carolina-harbor-waterpark/
The winners of the Natural Light - International Design Competition have now been chosen from the 172 impressive Natural Light Lamp designs submitted from 65 countries around the world. The winners are two very talented Argentinian Industrial Design students, Ms. Mariana Arando and Mr. Luca Fondello, both from the University of Buenos Aires, Argentina. The production phase of the winning design for the Natural Light Lamp will begin shortly, followed next year by shipment of the lamps to three African countries without access to electricity.
Last year, the VELUX Group and Little Sun joined forces to launch the Natural Light – International Design Competition, which challenged design students around the world to create a design for a solar lamp which would help to bring clean, reliable, affordable light to some of the 1.2 billion people worldwide living without electricity. Now the jury has voted and decided on the winning solar lamp design by two Industrial Design students from the University of Buenos Aires in Argentina.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7533451-velux-winner-announcement-natural-light/
ITC Transmission, a wholly-owned subsidiary of ITC Holdings Corp., the nation’s largest independent electricity transmission company, today announced its Thumb Loop high-voltage transmission project is complete with the energization of the third and final phase of the project. ITC invested an estimated $510 million to build the 345,000 volt (345 kV) line, which serves as the backbone of a system designed to meet the identified maximum wind energy potential of Michigan’s Thumb region. It also will contribute to regional system reliability and facilitate wholesale market competition.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7523851-itctransmission-thumb-loop/
Subaru of America, Inc. today announced the completion of a Pet Travel Seat Pilot Study as part of its continued partnership with Center for Pet Safety (CPS), a registered 501(c)(3) non-profit research and consumer advocacy organization. Subaru and CPS have tested pet products most commonly used by pet parents when traveling. Phase one tested pet harnesses, phase two tested pet crates and carriers, and now, phase three has tested pet travel seats.
A pet travel seat is typically used in a vehicle to hold or elevate the pet, but does not offer full containment. The Pet Travel Seat Pilot Study found that while a pet travel seat may offer distraction prevention, it will likely not offer crash protection in the event of an accident, which could lead to injury of the pet and the human vehicle passengers. The quality of commonly available pet travel seats did not provide effective protection in a crash scenario.
Based on the scientific test evidence collected over the past four years, in part through its partnership with Subaru, CPS can now identify the safest travel options for most pets. For small dogs and cats, Center for Pet Safety recommends one of the 2015 Top Performing Carriers; for medium and large dogs either the 2015 Top Performing Crate - Gunner Kennels G1 Intermediate with 8' Tie Down Straps, or a Center for Pet Safety Certified Harness. To view top performing products and CPS Certified products, visit www.CenterforPetSafety.org.
To view the multimedia release go to:
http://www.multivu.com/players/English/7074158-subaru-cps-pet-travel-seat-study/
Aurora Flight Sciences announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company the prime contract for Phase 2 of the Agency’s Vertical Takeoff and Landing Experimental Plane (VTOL X-Plane) program.
VTOL X-Plane seeks to develop a technology demonstrator that could:
• Achieve a top sustained flight speed of 300 kt-400 kt
• Raise aircraft hover efficiency from 60 percent to at least 75 percent
• Present a more favorable cruise lift-to-drag ratio of at least 10, up from 5-6
• Carry a useful load of at least 40 percent of the vehicle’s projected gross weight of 10,000-12,000 pounds
The Aurora team’s design for its unmanned aircraft, named LightningStrike, seeks to provide an approximately 50-percent increase in speed over existing VTOL aircraft designed for comparable mission applications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7617851-aurora-flight-sciences-vtol-xplane-darpa/
As a founding voice in the world of holistic wellness, Canyon Ranch® has the wisdom and expertise of spending nearly 40 years helping its guests achieve well-being. Now, the life-enhancement brand that’s built a devoted global following, is finally going global itself.
Under the guidance of the brand’s new Chief Executive Officer, Susan E. Docherty, the Company announced today the development of its first-ever international destination, Canyon Ranch Wellness Resort at Kaplankaya, on a spectacular peninsula of the sun-kissed Aegean coast. The initial phase of the Canyon Ranch development, which will open in July 2016, will include a strikingly modern resort and luxury real estate offerings. The property will integrate the signature wellness and lifestyle programming that has earned Canyon Ranch a famously loyal clientele worldwide.
To view the multimedia release go to:
http://www.multivu.com/players/English/7634751-canyon-ranch-resort-kaplankaya-turkey/
